| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 12.77▲ | 12.76▲ | 12.76▲ | 12.65▲ | 12.73▲ |
| MA10 | 12.77▲ | 12.75▲ | 12.71▲ | 12.73▲ | 12.68▲ |
| MA20 | 12.76▲ | 12.68▲ | 12.64▲ | 12.72▲ | 12.55▲ |
| MA50 | 12.70▲ | 12.63▲ | 12.69▲ | 12.65▲ | 12.21▲ |
| MA100 | 12.63▲ | 12.71▲ | 12.71▲ | 12.52▲ | 12.36▲ |
| MA200 | 12.65▲ | 12.69▲ | 12.65▲ | 12.16▲ | 12.22▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.010▲ | 0.025▲ | -0.012▼ | 0.010▲ |
| RSI | 72.040▲ | 76.169▲ | 72.081▲ | 55.823▲ | 60.810▲ |
| STOCH | 60.000 | 94.451▲ | 97.966▲ | 26.804 | 65.375 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -37.037 | -25.641 |
| CCI | 126.275▲ | 91.079 | 95.590 | 14.149 | 61.657 |
|
Thursday, January 22, 2026 07:44 AM
NervGen Pharma Corp., a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, ...
|
|
Tuesday, January 20, 2026 04:06 AM
Adam Rogers, MD, Chairman and Interim Chief Executive Officer will be joined by members of the NervGen management team, Board of Directors, advisors, and other guests.
|
|
Thursday, January 08, 2026 05:39 AM
(RTTNews) - NervGen Pharma Corp., (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biopharmaceutical company developing neuroreparative therapeutics for spinal cord injury and other neurotraumatic and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 12.68 | 12.78 | 12.67 | 12.78 | 488,609 |
| 27/01/26 | 12.55 | 12.67 | 12.525 | 12.67 | 525,740 |
| 26/01/26 | 12.68 | 12.71 | 12.55 | 12.55 | 703,500 |
| 23/01/26 | 12.63 | 12.657 | 12.585 | 12.64 | 727,149 |
| 22/01/26 | 12.73 | 12.73 | 12.6146 | 12.62 | 548,550 |
| 21/01/26 | 12.82 | 12.82 | 12.61 | 12.69 | 1,064,900 |
| 20/01/26 | 12.79 | 12.82 | 12.75 | 12.82 | 613,334 |
| 16/01/26 | 12.80 | 12.83 | 12.75 | 12.83 | 527,500 |
| 15/01/26 | 12.84 | 12.84 | 12.76 | 12.80 | 602,900 |
| 14/01/26 | 12.80 | 12.93 | 12.77 | 12.93 | 849,100 |
|
|
||||
|
|
||||
|
|